Sakk 38/19: Assessing a CTDNA and Pet-Oriented Therapy in Patients with DLBCL. A Multicenter, Open-Label, Phase II Trial.
Details
Serval ID
serval:BIB_673A6612EFD7
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
Title
Sakk 38/19: Assessing a CTDNA and Pet-Oriented Therapy in Patients with DLBCL. A Multicenter, Open-Label, Phase II Trial.
Title of the conference
Hematological oncology
Organization
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, 13 ‐ 17 June, 2023
Address
Lugano, Switzerland
ISSN
1099-1069 (Electronic)
ISSN-L
0278-0232
Publication state
Published
Issued date
06/2023
Peer-reviewed
Oui
Volume
41
Number
Suppl 2
Pages
165-166
Language
english
Keywords
Humans, Lymphoma/therapy, Switzerland, Congresses as Topic
Pubmed
Open Access
Yes
Create date
09/08/2024 15:44
Last modification date
10/08/2024 7:30